Drug Shortage Report for MITOXANTRONE INJECTION USP

Last updated on 2017-09-25 History
Report ID 1148
Drug Identification Number 02244614
Brand name MITOXANTRONE INJECTION USP
Common or Proper name MITOXANTRONE
Company Name PFIZER CANADA ULC
Active Ingredient(s) MITOXANTRONE HYDROCHLORIDE
Strength(s) 2mg
Dosage form(s) Solution
Route of administration Intravenous / Intraveineux
Packaging size 20mg/10mL x 1
ATC code L01DB
ATC description CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2015-08-21
Estimated end date 2017-09-25
Actual end date 2017-09-15
Shortage status Resolved
Updated date 2017-09-25
Company comments
Health Canada comments
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2017-09-25 French Compare
v8 2017-09-25 English Compare
v7 2017-07-19 French Compare
v6 2017-07-19 English Compare
v5 2017-06-29 French Compare
v4 2017-06-29 English Compare
v3 2017-06-29 English Compare
v2 2017-03-13 French Compare
v1 2017-03-13 English Compare